| Literature DB >> 31014352 |
Wouter T Gude1,2, Benjamin Brown3, Sabine N van der Veer4,3, Heather L Colquhoun5, Noah M Ivers6, Jamie C Brehaut7,8, Zach Landis-Lewis9, Christopher J Armitage4,10,11, Nicolette F de Keizer12, Niels Peek4,3.
Abstract
BACKGROUND: Audit and feedback (A&F) is a common quality improvement strategy with highly variable effects on patient care. It is unclear how A&F effectiveness can be maximised. Since the core mechanism of action of A&F depends on drawing attention to a discrepancy between actual and desired performance, we aimed to understand current and best practices in the choice of performance comparator.Entities:
Keywords: Benchmarking; Feedback; Medical audit; Quality improvement
Mesh:
Year: 2019 PMID: 31014352 PMCID: PMC6480497 DOI: 10.1186/s13012-019-0887-1
Source DB: PubMed Journal: Implement Sci ISSN: 1748-5908 Impact factor: 7.327
Study characteristics
| Characteristic | Randomised controlled trials ( | Qualitative studies ( |
|---|---|---|
| Publication date | ||
| 2012–2016 | 2 (1) | 42 (65) |
| 2006–2011 | 36 (25) | 15 (23) |
| 1996–2005 | 76 (52) | 8 (12) |
| 1986–1995 | 20 (14) | – |
| Before 1986 | 12 (8) | – |
| Risk of bias | ||
| Low risk | 47 (32) | 9 (14) |
| Moderate/unclear | 73 (50) | 47 (72) |
| High | 26 (18) | 9 (14) |
| Continent | ||
| North America | 82 (56) | 22 (34) |
| Europe | 46 (32) | 37 (57) |
| Australia | 11 (8) | 2 (3) |
| Africa | 2 (1) | 2 (3) |
| Asia | 4 (2) | 0 (0) |
| South America | 0 (0) | 2 (3) |
| Clinical setting | ||
| Outpatient | 99 (68) | 31 (48) |
| Inpatient | 37 (25) | 30 (46) |
| Other/unclear | 10 (7) | 4 (7) |
| Clinical topic | ||
| Diabetes/cardiovascular disease management | 32 (22) | 20 (31) |
| Laboratory testing/radiology | 21 (14) | 0 (0) |
| Prescribing | 33 (23) | 11 (17) |
| Other (e.g. preventive care, nursing, surgery) | 52 (36) | 34 (52) |
Potential mechanisms and effects of clinical performance comparators and their theoretical and empirical support
| Comparator | Potential mechanisms and effects | Theoretical and empirical support |
|---|---|---|
| Benchmarks | Increases feedback effectiveness by reducing complexity (enabling comparison with others enables recipients to better understand how well they are performing and which areas require improvement) and increasing social influence (by harnessing competition between recipients, changing recipients’ behaviour if they see others behaving differently, and trying to maintain their status in a group of high performing clinicians). | Theories ( |
| Debilitates feedback effectiveness by directing attention away from the performance task at hand (e.g. prescribing appropriate medication) which allows recipients to explain away potentially bad performance if overall performance is low. | Theories ( | |
| Induces both positive and negative emotions dependent on whether relative performance level is high or low respectively by increasing competition through social influence. | Theories ( | |
| Benchmarking against a | Theories ( | |
| Benchmarking against | Theories ( | |
| Benchmarking against | Theories ( | |
| Benchmarking against | Theories ( | |
| Benchmarking against | Qualitative studies ( | |
| Theories ( | ||
| Theory: Social Comparison Theory [ | ||
| Trends | Facilitates action by decreasing the complexity in a way that helps recipients interpret and identify when clinical performance requires action, in particular, if the | Theories ( |
| Increases the observability of the feedback intervention which induces positive emotions by demonstrating how recipients’ clinical performance has improved over time as a consequence of their taken actions; higher improvement rates being associated with higher satisfaction. | Theories ( | |
| Facilitates acceptance of feedback by increasing its credibility because performance is measured during a | Qualitative studies ( | |
| Explicit targets | Facilitates action by reducing complexity of the feedback, making it easier for recipients to know what constitutes ‘good performance’ and therefore what requires a corrective response. | Theories ( |
| Targets from an external | Theories ( | |
| Self-set targets (i.e. | Theories ( | |
| Ambitious target | Theories ( | |
| Absolute target | Theories ( | |
| Relative targets based on benchmarking facilitate continuous quality improvement as can be automatically adjusted when the group performance changes, but also inhibits action because it creates uncertainty to recipients as to which performance levels should be targeted. | Qualitative studies ( | |
| Relative target | Qualitative studies ( |
Performance comparators used in the 146 included audit and feedback interventions
| Performance comparators | |
|---|---|
| Benchmarks | 88 (60.3) |
| Reference group | |
| Region | 39 (24.7) |
| State or province | 26 (17.8) |
| Country | 21 (14.4) |
| Unit or department, e.g. individual physicians within a hospital | 12 (8.2) |
| Multistate | 5 (3.4) |
| Same type units, e.g. teaching hospitals | 3 (2.1) |
| Other: city or small group | 4 (2.7) |
| Values | |
| Mean | 37 (25.3) |
| Individual peer scores—anonymous or unclear if identifiable | 23 (15.8) |
| Top 10% mean (or ABC benchmarka) | 7 (4.8) |
| Median | 6 (4.1) |
| Other percentiles, e.g. 75th or 80th percentile | 6 (4.1) |
| Rank or percentile rank | 4 (2.7) |
| Individual peer scores—identifiable | 3 (2.1) |
| Other, e.g. min-max or standard deviation | 3 (2.1) |
| Unclear | 22 (15.1) |
| Trends | 17 (9.6) |
| Reference period | |
| Previous 1–6 quarters | 7 (4.8) |
| Previous 1–12 months | 4 (2.7) |
| Previous 1–6 half years | 2 (1.4) |
| Previous 1–15 weeks | 2 (1.4) |
| Previous 1 year | 1 (0.7) |
| Unclear | 1 (0.7) |
| Explicit targets | 16 (11.0) |
| Source | |
| Investigators | 5 (3.4) |
| Feedback recipients or local management (i.e. self-set targets) | 5 (3.4) |
| Expert panel | 3 (2.1) |
| Other: government or guideline | 3 (2.1) |
| Unclear | 1 (0.7) |
| Values | |
| Absolute targets, e.g. 80% performance level | 6 (4.1) |
| Relative targets based on benchmarking, e.g. 80th percentile of baseline peer performance | 6 (4.1) |
| Relative targets based on trends, e.g. 20% improvement from baseline | 3 (2.1) |
| Unclear | 1 (0.7) |
| No comparators or unclear | 48 (32.9) |
Items are not mutually exclusive
aABC benchmark achievable benchmark of care, defined as the mean performance level achieved by the top 10% [64]